Evidence map›Paper›PMID 19996900›Full record

ArticleJournal of developmental and behavioral pediatrics : JDBP2009

Broad clinical involvement in a family affected by the fragile X premutation.

Weerasak Chonchaiya, Agustini Utari, Gabriela Marques Pereira, Flora Tassone, David Hessl, Randi J Hagerman

Abstract readCase Reports
In one paragraph

Article in Journal of developmental and behavioral pediatrics : JDBP, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Evidence for the role of FMR1 gray zone alleles as a risk factor for parkinsonism in females.Movement disorders : official journal of the Movement Disorder Society · 2018
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. A novel assay for evaluating fragile X locus repeats.The Journal of molecular diagnostics : JMD · 2011
    Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Weerasak ChonchaiyaM.I.N.D. Institute, University of California-Davis Medical Center, Sacramento, CA, USA.
Agustini Utari
Gabriela Marques Pereira
Flora Tassone
David Hessl
Randi J Hagerman

Funding

Restoring FMRP Phenotypes Frpm Temporal Regional and Splice- Isoforms VarationsP30HD002274 · NICHD · UNIVERSITY OF WASHINGTON · PI GURALNICK, MICHAEL J · 1985 to 2013
$33.6M
GENOTYPE/PHENOTYPE RELATIONSHIPS IN FRAGILE X FAMILIESR01HD036071 · NICHD · UNIVERSITY OF CALIFORNIA DAVIS · PI PAUL J HAGERMAN, RANDI J. HAGERMAN · 1998 to 2026
$13.8M
Characterization and Treatment of CNS Abnormalities in Premutation Carriers (4 ofRL1AG032115 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HAGERMAN, RANDI J. · 2007 to 2011
$5.8M
Trajectories and Markers of Neurodegeneration in Fragile X Premutation CarriersR01MH078041 · NIMH · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HESSL, DAVID R, RIVERA, SUSAN M · 2007 to 2017
$5.4M
Interdisciplinary Training Program in Neurotherapeutics (6 of 6)TL1DA024854 · NIDA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CARTER, CAMERON S. · 2007 to 2011
$835k
Genetics and Physiology of Social Anxiety in Fragile XK23MH077554 · NIMH · UNIVERSITY OF CALIFORNIA DAVIS · PI HESSL, DAVID R · 2005 to 2009
$772k
A Standard Information Model for General Dental RecordsR21DE019683 · NIDCR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SCHLEYER, TITUS K. · 2010 to 2011
$414k
NCBDD CDC HHS U50 DD000596NIA NIH HHS AG032115NIA NIH HHS RL1 AG032115NICHD NIH HHS HD02274NICHD NIH HHS HD036071NICHD NIH HHS P30 HD002274NICHD NIH HHS R01 HD036071NIDA NIH HHS DA024854NIDA NIH HHS TL1 DA024854NIDCR NIH HHS DE019683NIDCR NIH HHS R21 DE019683NIMH NIH HHS K23 MH077554NIMH NIH HHS R01 MH078041
6 · The paper itself

Abstract

The mutations in the FMR1 gene have been described as a family of disorders called fragile X-associated disorders including fragile X syndrome, fragile X-associated tremor/ataxia syndrome, primary ovarian insufficiency, and other problems associated with the premutation, such as hypothyroidism, hypertension, neuropathy, anxiety, depression, attention-deficit hyperactivity disorders, and autism spectrum disorders. The premutation is relatively common in the general population affecting 1 of 130 to 250 female individuals and 1 of 250 to 800 male individuals. Therefore, to provide appropriate treatment and genetic counseling for all of the carriers and affected individuals in a family, a detailed family history that reviews many of the disorders that are related to both the premutation and the full mutation should be carried out as exemplified in these cases. To facilitate the integration of this knowledge into clinical practice, this is the first case report that demonstrates only premutation involvement across 3 generations.

Indexed as

FamilyAdultAutistic DisorderChildFemaleFragile X Messenger Ribonucleoprotein 1HeterozygoteHumansMaleMiddle AgedPedigreePhenotypeFMR1 protein, humanFragile X Messenger Ribonucleoprotein 1

Identifiers

PMID19996900
PMCPMC2822648

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.